Starting October 27th, the Company will use NASDAQ Ticker Symbol: RPTP NOVATO, Calif., Oct. 27 /PRNewswire-FirstCall/ -- Raptor Pharmaceutical...
Primary Endpoint Achieved in Completed Treatment Phase NOVATO, Calif., Oct. 12 /PRNewswire-FirstCall/ -- Raptor Pharmaceutical Corp. ("Raptor" or...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NOTICE OF EFFECTIVENESS Effective Date: October 01, 2009...
FORM 4 [ X ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...
NOVATO, Calif., Oct. 1 /PRNewswire-FirstCall/ -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (NASDAQ:RPTPD), today announced the...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 15 OMB APPROVAL OMB Number: 3235-0167...
AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON SEPTEMBER 30, 2009 Registration Statement File No. 333-152420 ...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.